Strata Critical Medical, Inc.
SRTA
$4.14
-$0.11-2.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 35.48% | 84.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 35.48% | 84.29% | |||
| Cost of Revenue | 46.26% | 80.43% | |||
| Gross Profit | 0.48% | 98.06% | |||
| SG&A Expenses | 19.15% | 76.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 41.06% | 80.49% | |||
| Operating Income | -518.02% | 34.65% | |||
| Income Before Tax | 44.21% | -539.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 44.21% | -532.00% | |||
| Earnings from Discontinued Operations | -105.14% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -115.38% | 1,633.96% | |||
| EBIT | -518.02% | 34.65% | |||
| EBITDA | -253.16% | -117.69% | |||
| EPS Basic | -114.98% | 1,610.41% | |||
| Normalized Basic EPS | -354.55% | 46.67% | |||
| EPS Diluted | -115.04% | 1,604.34% | |||
| Normalized Diluted EPS | -354.55% | 46.67% | |||
| Average Basic Shares Outstanding | 2.72% | 2.29% | |||
| Average Diluted Shares Outstanding | 2.72% | 2.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||